Cme Slides Forum

CME SLIDES FORUM

Archive

	Determinants of long term progression - results from the MMKD study		Magic bullet or multiple interventions to reverse kidney disease progression?
Prof F. Kronenberg Division of Genetic Epidemiology Department of Medical Genetics Molecular and Clinical Pharmacology Innsbruck Medical University Innsbruck, Austria		Prof G. Remuzzi Mario Negri Institute for Pharmacological Researches Negri Bergamo Laboratories Bergamo, Italy

	Tubular toxicity of proteinuria		Anti-proteinuric doses of RAS inhibitors: efficacy for renoprotection
Prof N.J. Brunskill Department of Infection, Immunity and Inflammation University of Leicester Leicester, United Kingdom		Prof F.F. Hou Division of Nephrology Nanfang Hospital Southern Medical University Guangzhou, P.R.China

	The complexity of the filtration barrier
Prof D. Kerjaschki Department of Pathology Medical University of Vienna Allgemeines Krankenhaus Vienna, Austria

	Hepcidin - bringing new knowledge of molecular mechanisms into the clinic		How well controlled is hyperparathyroidism in today's practice? The magnitude of the problem
Dr Dorine W. Swinkels Department of Clinical Chemistry Radboud University Nijmegen Medical Centre Nijmegen, The Netherlands		Prof J. Cannata-Andia Servicio de Metabolismo Oseo y Mineral Instituto “Reina Sofía” de Investigación. REDinREN – ISCIII. Hospital Universitario Central de Asturias. Universidad de Oviedo Oviedo, Spain

	Mechanisms underlying parathyroid hyperplasia		Bone as an endocrine organ: FGF 23 and the parathyroid
Dr. Adriana S. Dusso Renal Division Washington University School of Medicine St. Louis, MO, USA		Prof Justin Silver Department of Nephrology and Hypertension Hadassah University Hospital Ein-Karem, Jerusalem

	Intestinal signals regulate renal solute excretion		Cardiotonic steroids (endogenous digitalis)
Dr R. Kumar Division of Nephrology and Hypertension Department of Medicine, Mayo Clinic Rochester, MN, USA		Dr Alexei Y. Bagrov Laboratory of Cardiovascular Science National Institute on Aging, NIH Baltimore, MD, USA

	Non-osmotic sodium storage		Management of the ckd patient: salt restriction, diuretics or both?
Dr Jens Titze Medizinische Klinik 4 Nikolaus-Fiebiger Center for Molecular Medicine Erlangen, Germany		Prof B. Rodriguez-Iturbe Hospital Universitario de Maracaibo Centro de Investigaciones Biomedicas Maracaibo, Venezuela

	The role of rituximab in vasculitis therapy		New experimental data on the pathogenesis of ANCA associated vasculitis
Dr David Jayne University of Cambridge School of Clinical Medicine Addenbrooke's Hospital Cambridge, United Kingdom		Dr Renate Kain Institute of Clinical Pathology Medical University of Vienna Vienna, Austria

	B cells and the kidney		Lupus nephritis: clinical trials and novel therapies
Dr Betty Diamond The Feinstein Institute for Medical Research Center of Autoimmune and Musculoskeletal Diseases Manhasset, NY, USA		Dr Charles Pusey Faculty of Medicine Imperial College London, United Kingdom

	Diagnostic criteria for protein-energy wasting		Therapeutic interventions for protein-energy wasting in chronic kidney diseases
Dr Denis Fouque Department of Nephrology Hospital Edouard Herriot University Lyon 1 Lyon, France		Prof. William E. Mitch Department of Nephrology Hospital Edouard Herriot University Lyon 1 Lyon, France

	Achieving blood pressure control and the risk of intradialytic hypotension
Dr Andrew Davenport University College London Center for Nephrology Royal Free Hospital London, United Kingdom

	Evidence-based therapy for idiopathic membranous nephropathy-2009		Immune mechanisms of interstitial inflammation in membranous nephropathy
Prof. Richard Glassock The David Geffen School of Medicine at UCLA Los Angeles, CA, USA		Prof. David Harris Department of Renal Medicine and Transplantation The University of Sydney at Westmead Hospital Westmead, Australia

	Natural history and prognostic factors		Complement components in membranous nephropathy
Prof C. Ponticelli IRCCS Istituto Auxologico Italiano Milan, Italy		Prof. Richard J. Quigg Section of Nephrology University of Chicago Chicago, IL, USA

	Interstitial and infection related nephritis
Prof. Jan A. Bruijn Department of Pathology Leiden University Hospital Leiden, The Netherlands

	Blood pressure effects of VEGF antagonism		VEGF antagonism as a cause of preeclampsia
Dr Michel Azizi Clinical Investigation Center, Inserm George Pompidou European Hospita, APHP Paris, France		Dr Sharon E. Maynard School of Medicine George Washington University Washington, D.C., USA

	ADMA, blood pressure and renal function: from saltsensitivity to heart failure		ADMA, endothelial dysfunction and the risk of cardiovascular and renal diseases
Prof D. Fliser Renal and Hypertensive Disease University Medical Centre Homburg/Saar, Germany		Prof C. Zoccali Unità di Nefrologia, Dialisi, Trapianto e Ipertensione OO.RR and CNR Istituto di Biomedicina Laboratorio di Epidemiologia Clinica e Fisiopatologia delle Malattie Renali e dell'Ipertensione Reggio Calabria, Italy

	Classical and non classical nitric oxide signaling in vascular disease
Dr S. Lamas Centro Nacional de Investigaciones Cardiovasculares Consejo Superior de Investigaciones Científicas Madrid, Spain

	New membranes		Use of the serum free light chain assay
Dr Colin A. Hutchison Department of Nephrology University Hospital Birmingham Birmingham, United Kingdom		Dr Helen J. Lachmann UK National Amyloidosis Centre University College London Medical School London, United Kingdom

	The use of plasmapheresis		Indications to plasma infusion and plasma exchange
Dr François Madore University of Montréal Hôpital du Sacré-Coeur de Montréal Montréal, Quebec, Canada		Prof. C. Loirat Service de Nephrologie Pediatrique Hopital Robert Debre Paris, France

	Natural course and perspectives for medical therapy in AA amyloidosi
Dr. Martha Skinner Amyloid Treatment and Research Program Boston University School of Medicine Boston, USA

	The renal epithelial sodium channel and hypertension		WNK kinases and hypertension
Prof David G. Warnock Department of Nephrology University of Alabama at Birmingham Birmingham, AL, USA		Prof Xavier Jeunemaitre INSERM U772 Collège de France Paris, France

	Finding the genes of hypertension: lessons from the hypergenes project		Lessons from autosomal dominant hypertension and brachydactylie
Prof Daniele Cusi Division of Nephrology and Dialysis San Carlo Borromeo Hospital Milano, Italy		Prof Friedrich C. Luft Charité Campus Buch Experimental and Clinical Research Center (ECRC) Berlin, Germany

	ASTRAL study: results and implications		Results of the STAR study
Dr Philip A. Kalra Department of Renal Medicine Salford Royal Hospital Salford, United Kingdom		Dr. Jaap J. Beutler Jeroen Bosch Hospital, Den Bosch University Medical Center Utrecht, The Netherlands

	Long-term kidney graft survival - are we doing any better?		Early EMT in renal grafts is correlated with outcome
Prof Gerhard Opelz Department of Transplantation Immunology University of Heidelber Heidelberg, Germany		Prof Eric Rondeau Service de Nephrologie A Hopital Tenon Paris, France

	The pro and con of protocol biopsies		Renin-angiotensin system blockade in kidney transplantation
Prof Hermann Haller Division of Nephrology Department of Medicine, School of Medicine University of Hannover Hannover, Germany		Prof Jack F.M. Wetzels Department of Nephrology Radboud University Nijmegen Nijmegen, The Netherlands

	Progression of FABRY nephropathy		Treatment choices for FABRY nephropathy
Dr R. Schiffmann Institute of Metabolic Disease Baylor Research Institute Dallas, TX, USA		Prof C.Wanner Bayerische-Julius-Maximilans University Department of Medicine, Division of Nephrology Würzburg, Germany

	Transplant, dialysis and CVD in FABRY disease
Dr R. Mignani Renal Unit Infermi Hospital Rimini, Italy

	Evaluation of physical activity in CKD: applicability of simple too		Asessment of functional capacity in CKD patients
Dr L. Cuppari Division of Nephrology Federal University of Sao Paulo Sao Paulo, Brazil		Dr P. Koufaki Department of Sports and Exercise Science Stirling University Stirling, United Kingdom

	Growth hormone improves nutrition, quality of life and cardiovascular risk factors in ESRD
Dr B. Feldt-Rasmussen Department of Nerphrology Rigshospitalet Copenhagen, Denmark

	Intestinal phosphate absorption: cross-talk with the kidney		Molecular control of renal phosphate reabsorption
Dr R. Kumar Division of Nephrology and Hypertension Department of Medicine, Mayo Clinic Rochester, MN, USA		Prof. Heini Murer Center for Integrative Human Physiology University of Zurich Zurich, Switzerland

	Phosphate, pyrophosphate and bisphosphonates in uremic vascular calcification		FGF23 and klotho in patients with CKD
Prof. W. Charles O'Neill Renal Division Emory University Atlanta, GA, USA		Dr. M. Fukagawa Division Nephrology and Kidney Center Kobe University School of Medicine Kobe, Japan

The interplay between hyperglycemia and vascular hemodynamics

Advanced glycation, hypoxia and oxidative stress

Dr. Luigi Gnudi
Unit for Metabolic Medicine, Cardiovascular Division
King's College London
London, United Kingdom

Prof. T. Miyata
Center for Translational and Advanced Research
Tohoku University Graduate School of Medicine
Sendai, Japan

An integrated proteomic approach to plasma and urinary proteins in nephrotic syndrome

FSGS - primary vs. Secondary forms, congenital mutations vs non-genetic types

Dr. G.M. Ghiggeri
Department of Nephrology
Dialysis and Transplantation
Giannina Gaslini Children Hospital
Genova, Italy

Dr. M.C. Gubler
Inserm U574, Ventre de reference MARHEA
Hopital Necker - Enfant Malades
Université Paris Descartes
Paris, France

Tropical infections and glomerulonephritis

Dr. M.R. Francis
Pathology Department
Kasr El Aini Faculty of Medicine
Cairo, Egypt

	Fairness (and its limits) in humans		Lymphangiogenesis in development and disease
Prof. E. Fehr Institute for Empirical Research in Economics University of Zurich Zurich, Switzerland		Prof. K. Alitalo Molecular/Cancer Biology Laboratory Biomedicum Helsinki and Department of Pathology Haartman Institute, University of Helsinki Helsinki, Finland

	Remote ischemic preconditioning
Dr. D.M. Hausenloy The Hatter Cardiovascular Institute University College London London, United Kingdom